340B Plan B: Pharma Pivots To Rebate Pricing Model After Pharmacy Restrictions Fall Short

 
• By Cathy Kelly
  
Manufacturers are pivoting to back-end rebates in the 340B program. (Shutterstock)

More from Pricing Debate

More from Geography